Dulaglutide vs Semaglutide
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Dulaglutide or Semaglutide?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Dulaglutide and Semaglutide?
The weight loss gap (~15% vs. ~3-4%) and CV risk reduction gap (HR 0.80 vs. 0.88) consistently favor semaglutide - making dulaglutide a second-choice GLP-1 agonist in most therapeutic contexts where maximum efficacy is prioritized.
Evidence Comparison
Semaglutide: SELECT trial HR 0.80 for MACE (n=17,604), STEP trials 14.9% weight loss. Dulaglutide: REWIND HR 0.88 for MACE, ~4.6 kg weight loss. Semaglutide outperforms on both weight and CV endpoints.
Evidence Context Favoring Dulaglutide
Cost-driven or formulary-driven decisions where dulaglutide access is better, or specific patient preference for the Trulicity delivery device.
Evidence Context Favoring Semaglutide
Maximum weight loss or CV risk reduction where semaglutide's superior STEP and SELECT data are clinically decisive.
Side-by-Side Snapshot
| Evidence grade | Dulaglutide: Level A Semaglutide: Level A |
|---|---|
| Research status | Dulaglutide: FDA Approved Semaglutide: FDA Approved |
| Primary category | Dulaglutide: Weight Loss & Metabolic Semaglutide: Weight Loss & Metabolic |
| Cited studies | Dulaglutide: 3 Semaglutide: 6 |